News Archive

Adaptive Phage Therapeutics (APT), a clinical-stage biotechnology company founded to provide an effective therapeutic response to the global rise of multi-drug resistant (MDR) pathogenic bacteria, today announced that the U.S. Food and Drug Administration (FDA) has cleared its Investigational New

The 2020 MEDA Award winner in the Economic Development Marketing category is TEDCO’s Entrepreneur Expo. Due to its strategic marketing, which made use of digital and multimedia advertising, the conference drew over 1,000 attendees for a day of pitching opportunities, workshops and roundtable

A visual vocabulary-learning app that is looking to change the way students learn and comprehend language recently received a $250,000 joint investment from the University System of Maryland’s Momentum Fund, which supports early-stage companies. InferCabulary, an app developed by speech and language

Some news out of this week’s RSA conference in San Francisco caught our attention back east: Iconic cybersecurity company McAfee announced plans to acquire Catonsville-based Light Point Security. When the deal finalizes, Light Point Security cofounders Zuly Gonzalez and Beau Adkins are slated to

InferCabulary, a Towson University Incubator-based education technology startup created to help solve illiteracy, received a $250,000 joint investment from the University System of Maryland (USM) Maryland Momentum Fund. The funding will be used to expand the team and to accelerate growth.

McAfee, the device-to-cloud cybersecurity company, today announced it has entered into a definitive agreement to acquire Light Point Security, LLC, an award-winning pioneer of browser isolation. Upon the close of the acquisition, the Light Point Security team will join McAfee.

Volume 2020

Computer scientist Russell Taylor and chemical and biomolecular engineer Yannis Kevrekidis are among 87 new members and 18 international members selected this year.

Enter a new treatment called 'phage therapy' and Greg Merril, CEO and co-founder of Adaptive Phage Therapeutics in Gaithersburg.

A unique feature of the MII program is the introduction of university “site miners” to facilitate the application process for faculty inventors. These commercialization experts support faculty with preparing proposals and advocate for projects in the review process. UMBC site miner David Fink

IBBR receives TEDCO MII Funding

Linshom announced today U.S. Food and Drug Administration (FDA) 510(k) clearance of the company’s first product, a small, non-invasive respiratory monitor that addresses the growing need for continuous respiratory monitoring for patients susceptible to respiratory depression and compromise.

The visual vocabulary tool was awarded $25,000 in Google credit in recognition of its innovative approach as it moves into its next stage of growth

Theraly Fibrosis, a preclinical-stage biotechnology company focused on development and commercialization of drugs for various fibrotic diseases today announced the company has been awarded a Small Business Innovation Research (SBIR) Phase II grant by the National Institutes of Health (NIH) in the